Close
Show
Home Press Releases

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

 Catalent Launches OptiGel DR, a Delayed/Enteric Release Softgel for Pharmaceutical and Nutraceutical Applications

Catalent Launches OptiGel DR, a Delayed/Enteric Release Softgel for Pharmaceutical and Nutraceutical Applications


Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
Fujifilm Partners with Carelink Pharmaceutical in Deploying Anti-influenza Drug Avigan Tablets in China

Fujifilm Partners with Carelink Pharmaceutical in Deploying Anti-influenza Drug Avigan Tablets in China


FUJIFILM Toyama Chemical Co., Ltd. has announced that the company has partnered with Chinese pharmaceutical...
Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials

RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate


RedHill Biopharma, a specialty biopharmaceutical company, has announced collaborations with two specialist pharmaceutical manufacturers in...
BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research

BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery...


BioIVT, a leading provider of research models and services for drug and diagnostic development, launched...
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment


Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its...
TraceLink Announces New Serialized Product Intelligence Solution

TraceLink Announces New Serialized Product Intelligence Solution


TraceLink, Inc., the leading digital platform company for the life science supply chain, introduced Serialized...
Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to CPhI Annual Report

Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to...


The third part of the 2020 CPhI Annual Report – released during the second week...
Regeneron's Antibody Cocktail REGN-EB3 is First FDA-Approved Treatment for Ebola

Regeneron’s Antibody Cocktail REGN-EB3 is First FDA-Approved Treatment for Ebola


Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA approved Inmazeb® (atoltivimab, maftivimab and odesivimab-ebgn) for...
TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement

TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable...


TraceLink Inc., the leading digital platform company for the life sciences supply chain, announced that...
Merck's New VirusExpress Platform Speeds Development of Cell and Gene Therapies

Merck’s New VirusExpress Platform Speeds Development of Cell and Gene Therapies


Merck, a leading science and technology company, has bolstered its viral vector manufacturing capabilities with...